Incyte

INCYNasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$25.728 B

$126.93 +1.83%

Close of 22 Sept 2026

Revenue

$5.14B

#659 by revenue

Earnings

$1.29B

#323 by earnings

Shares outstanding

202,697,746

Latest filing cover page

P/E ratio

20.0

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#1IqviaIQV$44.5B
#2IncyteINCY$25.7B
#3MedpaceMEDP$17.6B
#4Charles River Laboratories InternationalCRL$13.6B
#5IconICLR$12.8B

What if Incyte were worth as much as…

Open the what-if tool →

Gold $30.2T

$149,157.90

Per share 1,175× higher

Bitcoin $1.74T

$8,592.38

Per share 67.7× higher

Nvidia $5.52T

$27,211.78

Per share 214× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Incyte are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.